J&J Bets Big on Cancer Treatment

Johnson & Johnson made a big move in the fight against cancer. It paid Sail Biomedicines $785 million. This deal could lead to J&J buying Sail Biomedicines completely. J&J wants to explore new cancer treatments called CAR-T therapies.

CAR-T therapy is a special kind of treatment. It uses a patient's own immune cells. Doctors change these cells in a lab. Then, they put the changed cells back into the body. These new cells find and kill cancer cells.

The drugs from Sail Biomedicines are different. They might let doctors make these changes inside the body. This could make CAR-T therapy easier to get. It may also lower the cost for patients.

This investment shows how committed J&J is to finding new cancer solutions. The company hopes this technology will help many people. It brings powerful new tools to the fight against cancer.

Source: FierceBiotech